Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000003

PRESIDENT AND COO sold 7,875 shares at an average $487.38 ($3,838,085)

  • PRESIDENT AND COO acquired 7,875 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Option exercise 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −376 $480.68 $180,737 7,499 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −891 $481.86 $429,339 6,608 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −471 $482.72 $227,360 6,137 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −375 $483.80 $181,427 5,762 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −629 $484.99 $305,061 5,133 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −899 $486.05 $436,959 4,234 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −461 $487.40 $224,693 3,773 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −641 $488.38 $313,049 3,132 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −364 $489.49 $178,174 2,768 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −893 $490.11 $437,669 1,875 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −647 $491.35 $317,903 1,228 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −598 $492.44 $294,482 630 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −201 $493.47 $99,188 429 I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −429 $494.27 $212,043 0 I
Derivatives
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Option exercise · Stock Options 10b5-1 −7,875 52,315 I
Open-market sales · 7,875 sh · avg $487.38 · $3,838,085
Loading xslF345X05/primarydocument.xml…